JPRN-UMIN000019736已完成未知
The examination of the efficacy by adverse reaction changing the treatment with Oxybutynin or Mirabegron on the patient who cannot go on treatment with anticholinergic agent - The examination of the efficacy by adverse reaction changing the treatment with Oxybutynin or Mirabegron on the patient who cannot go on treatment with anticholinergic agent
Department of Urology, Shiga University of medical science0 个研究点目标入组 15 人开始时间: 2015年11月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •contraindication of the medicine acute urinary retension within 12 months residual urine over 100mL urinary infection a1 blacker within 4 weeks
研究者
相似试验
尚未招募
3 期
Evaluation of the effect of Medvac IVIg on PIDPrimary immunodeficiency disorder.D84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.D84.9IRCT20101012004920N9Medvac BioPharma Company50
已完成
不适用
Assessment of treatment efficacy and adverse effects of Microrelin in patient with prostate cancer.IRCT201109067457N4Pooyesh darou company40
进行中（未招募）
2 期
W-JHS MM01Multiple myelomaJPRN-jRCTs071180011Shibayama Hirohiko80
已完成
不适用
Evaluation of efficacy and safety of a response adapted therapy adding bortezomib in newly diagnosed, transplant ineligible multiple myeloma patients with insufficient efficacy by lenalidomide - dexamethasone (Rd) therapy.Multiple myelomaJPRN-UMIN000026498Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu80
尚未招募
Unknown
Comparision Of Efficay And Adverse Effects Of Two Topicals In Treatment Of Localised Alopecia Areata - METHOTREXATE ONE PERCENTAGE GEL TOFACITINIB Versus TWO PERCENTAGE GECTRI/2024/06/069460DR M Yashaswini